Additionally, studies have demonstrated that EPO can have neuroprotective effects (Fan et al., 2012), the production of EPO can be stimulated by anemic hypoxia in the brain, and anemia is an independent risk factor of cognitive decline (Sousa et al., 2018). Here, EPO is linked to anemia (phenotype).